[Transfer-factor therapy in a case of chronic herpes simplex myelitis (author's transl)].
D000328:Adult; D000956:Antigens, Viral / Q000032:analysis; D002555:Cerebrospinal Fluid / Q000276:immunology / Q000382:microbiology; D005260:Female; D006560:Herpes Labialis / Q000150:complications; D006561:Herpes Simplex / Q000188:drug therapy* / Q000276:immunology; D006801:Humans; D007070:Immunoglobulin A / Q000032:analysis; D007074:Immunoglobulin G / Q000032:analysis; D007075:Immunoglobulin M / Q000032:analysis; D007153:Immunologic Deficiency Syndromes / Q000188:drug therapy / Q000276:immunology; D009187:Myelitis / Q000188:drug therapy* / Q000276:immunology; D012008:Recurrence; D018139:Simplexvirus / Q000302:isolation & purification; D014165:Transfer Factor / Q000627:therapeutic use*
D000956:Antigens, Viral; D007070:Immunoglobulin A; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D014165:Transfer Factor
Transfer-Faktor-Therapie bei einem Fall von chronischer Herpes simplex Myelitis.